Supernus Pharmaceuticals Reports First Quarter 2012 Financial Results
News | 07 June 2012
ROCKVILLE, Md., Jun 7, 2012 (GlobeNewswire via COMTEX) -- Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) , a specialty pharmaceutical company, today reported consolidated financial results for the first quarter of 2012, and provided an update on key ...
Click on the link to read the full article at MarketWatch (press release)
(This link will open in a new window)
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Italy's pharma market slump set to continue, warns GlobalData
- Is failure to adopt business process management putting the pharma industry at risk?
